Download PDF
1 / Pages

Other users also viewed these articles

Etiotypes in COPD: a pro/con debate Alvar Agusti; Marc Miravitlles;
Arch Bronconeumol. 2024;60:678-81
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial Alvar Agusti; José Luis Lopez-Campos; Marc Miravitlles; Juan Jose Soler-Cataluña; Jose Maria Marin; Borja G. Cosio; Bernardino Alcázar-Navarrete; Jose Maria Echave-Sustaeta; Ciro Casanova; German Peces-Barba; Juan Pablo de-Torres; Alberto Fernandez-Villar; Julio Ancochea; Felipe Villar-Alvarez; Miguel Roman-Rodriguez; Jesus Molina; Juan Luis Garcia-Rivero; Cruz Gonzalez; Patricia Sobradillo; Rosa Faner; Carolina Peña; Raj Sharma; José Luis Izquierdo; Bartolome R. Celli;
Arch Bronconeumol. 2024;60:417-22
Peripheral Immune Cell Profiling Reveals Distinct Immune Hallmarks in Progressive Pulmonary Fibrosis Fernanda Hernandez-Gonzalez; Nuria Mendoza; Sandra Casas-Recasens; Tamara Cruz; Nuria Albacar; Gemma López-Saiz; Xavier Alsina-Restoy; Mauricio Rojas; Alvar Agusti; Jacobo Sellarés; Rosa Faner;
Arch Bronconeumol. 2023;59:681-4